Influenza

Members of the Pandemic Influenza Preparedness Framework Advisory Group

as of April 2015

Bios coming soon

  • Dr Olav Hungnes, Senior Scientist, Norwegian Institute of Public Health, Norway
  • Dr Huma Qureshi, Executive Director, Pakistan Medical Research Council, Pakistan (not participating in April 2015 meeting)
  • Professor Mahmudur Rahman, Director, Institute of Epidemiology, Disease Control and Research, Bangladesh (not participating in April 2015 meeting)
Share

WHO Public Notice and Comment Period

In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information” ) being considered for participation in such meetings are disclosed for public notice and comment.

The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.

The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.

The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization nor does it create a binding relationship between the expert and WHO.

The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publically in accordance with WHO practice.

To send a comment, please email pipframework@who.int prior to 14 April 2015